{"id":1328,"date":"2021-12-10T07:02:18","date_gmt":"2021-12-10T14:02:18","guid":{"rendered":"http:\/\/www.fcihr.ca\/prize\/?page_id=1328"},"modified":"2022-10-21T14:01:11","modified_gmt":"2022-10-21T21:01:11","slug":"dr-lorne-tyrrell-2021-friesen-prize","status":"publish","type":"page","link":"https:\/\/www.fcihr.ca\/prize\/dr-lorne-tyrrell-2021-friesen-prize","title":{"rendered":"Dr. Lorne Tyrrell, 2021 Friesen Prize"},"content":{"rendered":"

\"PDF\" <\/a>Click here to Download Brief Bio – Dr. Lorne Tyrrell<\/a><\/p>\n

\"\"<\/a><\/p>\n

CONGRATULATIONS,
\nDR. LORNE TYRRELL<\/span><\/span><\/strong><\/p>\n

Friends of CIHR is pleased to announce that Dr. David Lorne J. Tyrrell, Distinguished Professor at the University of Alberta, visionary clinician-scientist, creative virologist, entrepreneur and academic leader, is the recipient of the 2021 Henry G. Friesen International Prize in Health Research.<\/strong><\/p>\n

Toronto \u2013 December 10, 2021 \u2013 Dr. David Lorne J. Tyrrell, OC, AOE, MD, PhD, FRCP, FRSC, FCAHS, is a Distinguished Professor at the University of Alberta with major interests in the prevention and treatment of viral diseases. His multi-faceted career in academic medicine, virology, pharmaceutical enterprise, and dedicated advocacy for health research in Canada are being honoured with the 2021 Henry G. Friesen International Prize in Health Research. Dr. Lorne Tyrrell is a gold medalist at the University of Alberta, where he obtained an MD in 1968 and a PhD at Queen\u2019s University in 1972. He completed Internal Medicine and sub-specialty training in Infectious Diseases and post-doctoral training in Virology at the Karolinska Institute.<\/p>\n

Dr. Tyrrell led the Faculty of Medicine and Dentistry from 1994-2004 as Dean. In this capacity, Health Sciences at U Alberta flourished with major capital developments, including the Katz Group \u2013 Rexall Centre for Pharmacy and Health Research and the Li Ka Shing Centre for Health Research Innovation. During this period, Dr. Tyrrell assumed national responsibilities and chaired the Association of Canadian Medical Colleges , through which he facilitated the transition of the Medical Research Council to the Canadian Institutes of Health Research (CIHR). Dr. Tyrrell\u2019s leadership style, his prescience and sound judgement led to a number of important Board chairmanships, including the Institute of Health Economics (IHE), the Gairdner Foundation Board and memberships in the Science Advisory Board of Health Canada and the National Vaccine Task Force.<\/p>\n

Dr. Tyrrell\u2019s most celebrated life saving accomplishment in collaboration with Morris Robbins was the licensing of the first oral anti-viral drug for chronic HBV (Lamivudine) in 200 countries. This led to the establishment of the Li Ka Shing Institute of Virology in 2010 at the University of Alberta, where Dr. Tyrrell is its Founder and Director.<\/p>\n

Dr. Tyrrell has received numerous awards including the Prix Galien Canada Research Award (1998), the Gold Medal of the Canadian Liver Foundation (2000), Alberta Order of Excellence (2000), Officer of the Order of Canada (2002), the Frederic Newton Gisborne Starr Award of the Canadian Medical Association (2004), and Fellow of the Royal Society of Canada (2004). Dr. Tyrrell was inducted into the Canadian Medical Hall of Fame (2011) and he was awarded the Killam Prize for Health Science (2015). In 2018, he received the FCIHR Award of Honour.<\/p>\n

Dr. Tyrrell maintains active research programs in viral-host interactions, development of a HCV vaccine and an active program on SARS-CoV-2 vaccines, diagnostics, and antivirals. He has published more than 250 peer-reviewed papers. In his spare time, he tends to his 1000 acre farm.<\/p>\n

The Henry G. Friesen International Prize in Health Research, established in 2005 by the Friends of Canadian Institutes of Health Research (FCIHR), recognizes exceptional innovation by a visionary health leader of international stature. The $35,000 Friesen Prize is awarded annually. Dr. Lorne Tyrrell will deliver public talks in 2022 in conjunction with the Friesen Prize Program. For further information on Friends of CIHR and the Friesen International Prize, please visit: www.fcihr.ca or contact: Cristina S. Castellvi. Tel. #: (416) 506-1597. Email: fcihr@fcihr.ca<\/a><\/p>\n

——————————————————————————————————————–<\/p>\n

\"PDF\" Annonce – le Dr Lorne Tyrrell<\/a><\/p>\n

\"\"<\/a><\/p>\n

Les Amis des IRSC ont le plaisir d\u2019annoncer l\u2019attribution du Prix international Henry G. Friesen de la recherche en sant\u00e9 2021 au Dr David Lorne J. Tyrrell, professeur \u00e9m\u00e9rite \u00e0 l\u2019Universit\u00e9 de l\u2019Alberta, clinicien-chercheur visionnaire, virologue cr\u00e9atif, entrepreneur et leader universitaire.<\/strong><\/p>\n

Toronto \u2013 le 10 d\u00e9cembre, 2021 \u2013 Le Dr David Lorne J. Tyrrell, OC, AOE, MD, PhD, FRCP, FRSC, FCAHS, est professeur \u00e9m\u00e9rite \u00e0 l\u2019Universit\u00e9 de l\u2019Alberta et s\u2019int\u00e9resse de pr\u00e8s \u00e0 la pr\u00e9vention et au traitement des maladies virales. Sa carri\u00e8re aux multiples volets en m\u00e9decine universitaire, virologie, entreprise pharmaceutique et promotion de la recherche en sant\u00e9 au Canada est honor\u00e9e par le Prix international Henry G. Friesen de la recherche en sant\u00e9 2021. Le Dr Tyrrell est m\u00e9daill\u00e9 d\u2019or \u00e0 l\u2019Universit\u00e9 de l\u2019Alberta et il y a obtenu un doctorat en m\u00e9decine en 1968 et un doctorat \u00e0 l\u2019Universit\u00e9 Queen\u2019s en 1972. Ses \u00e9tudes en m\u00e9decine interne lui vaudront une sous-sp\u00e9cialit\u00e9 en maladies infectieuses et une formation postdoctorale en virologie \u00e0 l\u2019Institut Karolinska.<\/p>\n

Le Dr Tyrrell a dirig\u00e9 \u00e0 titre de doyen la Facult\u00e9 de m\u00e9decine et de dentisterie de 1994 \u00e0 2004. \u00c0 ce titre, les sciences de la sant\u00e9 de l\u2019Universit\u00e9 de l\u2019Alberta ont prosp\u00e9r\u00e9 gr\u00e2ce \u00e0 d\u2019importantes immobilisations nouvelles, notamment le Katz Group \u2013 Rexall Centre for Pharmacy and Health Research et le Li Ka Shing Centre for Health Research Innovation. Au cours de cette p\u00e9riode, le Dr Tyrrell a assum\u00e9 des responsabilit\u00e9s nationales et pr\u00e9sid\u00e9 l\u2019Association des facult\u00e9s de m\u00e9decine du Canada, qui lui a permis de faciliter la transition du Conseil de la recherche m\u00e9dicale aux instituts de recherche en sant\u00e9 du Canada (IRSC). Le style de leadership du Dr Tyrrell, sa pr\u00e9science et son bon jugement ont men\u00e9 \u00e0 diverses pr\u00e9sidences importantes de conseils d\u2019administration, dont celle de l\u2019Institut d\u2019\u00e9conomie de la sant\u00e9 (IHE) et de la Fondation Gairdner ainsi que l\u2019appartenance au Conseil consultatif scientifique de Sant\u00e9 Canada et au Groupe de travail national sur les vaccins.<\/p>\n

La r\u00e9alisation la plus notoire du Dr Tyrrell, en collaboration avec Morris Robbins, a \u00e9t\u00e9 l\u2019homologation dans 200 pays du premier m\u00e9dicament antiviral oral contre le VBH chronique (Lamivudine), qui a amen\u00e9 la cr\u00e9ation de l\u2019Institut de virologie Li Ka Shing en 2010 \u00e0 l\u2019Universit\u00e9 de l\u2019Alberta, dont le Dr Tyrrell est \u00e0 la fois fondateur et directeur.<\/p>\n

Le Dr Tyrrell est titulaire de nombreux prix, dont le Prix Galien Canada pour la recherche (1998), la M\u00e9daille d\u2019or de la Fondation canadienne du foie (2000), l\u2019Ordre d\u2019excellence de l\u2019Alberta (2000), le Prix Frederic Newton Gisborne Starr de l\u2019Association m\u00e9dicale canadienne (2004), le titre d\u2019officier de l\u2019Ordre du Canada (2002) et celui de membre de la Soci\u00e9t\u00e9 royale du Canada (2004). Le Dr Tyrrell a \u00e9t\u00e9 intronis\u00e9 au Temple de la renomm\u00e9e m\u00e9dicale canadienne (2011) et il a re\u00e7u le prix Killam pour les sciences de la sant\u00e9 (2015). En 2018, la FCIHR lui a d\u00e9cern\u00e9 le prix d\u2019honneur.<\/p>\n

Le Dr Tyrrell poursuit des programmes de recherche actifs sur les interactions virus-h\u00f4te, la mise au point d\u2019un vaccin contre le VHC et un programme actif sur les vaccins, diagnostics et antiviraux contre le SRAS-CoV-2. Il a publi\u00e9 plus de 250 articles \u00e9valu\u00e9s par des pairs. Dans ses temps libres, il exploite sa ferme de 1000 acres.<\/p>\n

Le Prix international Henry G. Friesen de la recherche en sant\u00e9, cr\u00e9\u00e9 en 2005 par les Amis des Instituts de recherche en sant\u00e9 du Canada (EDSI), reconna\u00eet l\u2019innovation exceptionnelle d\u2019un chef de file visionnaire d\u2019envergure internationale en sant\u00e9. Le prix Friesen, dot\u00e9 de 35 000 $, est d\u00e9cern\u00e9 chaque ann\u00e9e. Le Dr Lorne Tyrrell prononcera des conf\u00e9rences publiques en 2022 dans le cadre du programme concernant ce prix. Pour de plus amples renseignements sur les Amis des IRSC et le Prix international Friesen, veuillez consulter www.fcihr.ca ou communiquer avec Cristina S. Castellvi (t\u00e9l. 416-506-1597 et courriel : fcihr@fcihr.ca<\/a>).<\/p>\n